Kei Sato

Active 1967–2026

222
Papers
18,660
Citations
77
h-index
193
i10-index

Citations

Citations per year for Kei Sato1968: 1 citations1969: 2 citations1970: 3 citations1971: 1 citations1972: 1 citations1973: 3 citations1974: 1 citations1975: 1 citations1976: 2 citations1977: 1 citations1978: 1 citations1979: 1 citations1980: 1 citations1981: 1 citations1982: 4 citations1983: 1 citations1984: 5 citations1985: 8 citations1986: 9 citations1987: 12 citations1988: 16 citations1989: 15 citations1990: 13 citations1991: 26 citations1992: 20 citations1993: 20 citations1994: 26 citations1995: 21 citations1996: 31 citations1997: 24 citations1998: 35 citations1999: 25 citations2000: 42 citations2001: 48 citations2002: 45 citations2003: 51 citations2004: 54 citations2005: 35 citations2006: 32 citations2007: 28 citations2008: 39 citations2009: 60 citations2010: 53 citations2011: 69 citations2012: 39 citations2013: 66 citations2014: 75 citations2015: 83 citations2016: 96 citations2017: 90 citations2018: 111 citations2019: 210 citations2020: 351 citations2021: 688 citations2022: 1,172 citations2023: 777 citations2024: 1,000 citations2025: 337 citations2026: 17 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,376 citing papers, 18.8% of this breakdownChina: 790 citing papers, 10.8% of this breakdownBrazil: 532 citing papers, 7.3% of this breakdownJapan: 497 citing papers, 6.8% of this breakdownUnited Kingdom: 453 citing papers, 6.2% of this breakdownGermany: 336 citing papers, 4.6% of this breakdownAustralia: 292 citing papers, 4% of this breakdownIndia: 232 citing papers, 3.2% of this breakdownCanada: 230 citing papers, 3.1% of this breakdownFrance: 218 citing papers, 3% of this breakdownItaly: 180 citing papers, 2.5% of this breakdownSpain: 127 citing papers, 1.7% of this breakdown
0%18.8%Other 28%

Fields

  • Medicine50.5%
  • Earth and Planetary Sciences15.5%
  • Biochemistry, Genetics and Molecular Biology13.1%
  • Immunology and Microbiology6.5%
  • Engineering4.3%
  • Agricultural and Biological Sciences2.7%
  • Other7.4%

Topics

  • SARS-CoV-2 and COVID-19 Research12.3%
  • COVID-19 Clinical Research Studies6.4%
  • Geological and Geochemical Analysis5.3%
  • Geochemistry and Geologic Mapping5.2%
  • SARS-CoV-2 detection and testing3.1%
  • earthquake and tectonic studies2.9%
  • Other64.8%

Coauthors

All papers

Open in search
  1. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miki Iida, Keiko Kasahara, Koshiro Tabata, Mariko Ishizuka, Asako Shigeno, Kenzo Tokunaga, Seiya Ozono, Isao Yoshida, So Nakagawa, Jiaqi Wu, Miyoko Takahashi, Atsushi Kaneda, M. Seki, Ryoji Fujiki, Bahityar Rahmutulla Nawai, Yutaka Suzuki, Yukie Kashima, Kazumi Abe, Kiyomi Imamura, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kayoko Nagata, Yugo Kawai, Yohei Yanagida, Yusuke Tashiro, Otowa Takahashi, Kazuko Kitazato, Haruyo Hasebe, Chihiro Motozono, Mako Toyoda, Toong Seng Tan, Isaac Ngare, Takamasa Ueno, Akatsuki Saito, Erika P. Butlertanaka, Yuri Tanaka, Nanami Morizako, Hirofumi Sawa, Terumasa Ikeda, Takashi Irie, Keita Matsuno, Shinya Tanaka, Takasuke Fukuhara, Kei Sato - Nature 2022 cited by 754

  2. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Sadamasu, Kazuhisa Yoshimura, Yuki Yamamoto, Tetsuharu Nagamoto, Gideon Schreiber, Katsumi Maenaka, Hayato Ito, Naoko Misawa, Izumi Kimura, Mai Suganami, Mika Chiba, Ryo Yoshimura, Kyoko Yasuda, Keiko Iida, Naomi Ohsumi, Adam Strange, Otowa Takahashi, Kimiko Ichihara, Yuki Shibatani, Tomoko Nishiuchi, Marie Kato, Zannatul Ferdous, Hiromi Mouri, Kenji Shishido, Hirofumi Sawa, Rina Hashimoto, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Tateki Suzuki, Kanako Kimura, Yukari Nakajima, So Nakagawa, Jiaqi Wu, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Kayoko Nagata, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Takashi Irie, Ryoko Kawabata, Chihiro Motozono, Mako Toyoda, Takamasa Ueno, Takao Hashiguchi, Terumasa Ikeda, Takasuke Fukuhara, Akatsuki Saito, Shinya Tanaka, Keita Matsuno, Kazuo Takayama, Kei Sato - Nature Communications 2023 cited by 347

  3. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kazuhisa Yoshimura, Akifumi Takaori‐Kondo, Masaki Imai, Mika Chiba, Hirotake Furihata, Haruyo Hasebe, Kazuko Kitazato, Haruko Kubo, Naoko Misawa, Nanami Morizako, Kohei Noda, Akiko Oide, Mai Suganami, Miyoko Takahashi, Kana Tsushima, Miyabishara Yokoyama, Yue Yuan, Shinya Tanaka, So Nakagawa, Terumasa Ikeda, Takasuke Fukuhara, Yoshihiro Kawaoka, Kei Sato - Nature 2021 cited by 689

  4. Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant

    Authors: , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2023 cited by 149

  5. Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant

    Authors: , , , , , , - The Lancet Infectious Diseases 2023 cited by 151

  6. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Host & Microbe 2021 cited by 591

  7. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gideon Schreiber, Saori Suzuki, Marie Kato, Zannatul Ferdous, Hiromi Mouri, Kenji Shishido, Naoko Misawa, Izumi Kimura, Yusuke Kosugi, Pan Lin, Mai Suganami, Mika Chiba, Ryo Yoshimura, Kyoko Yasuda, Keiko Iida, Naomi Ohsumi, Adam Strange, Daniel Sauter, So Nakagawa, Jiaqi Wu, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Yukari Nakajima, Hisano Yajima, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Kayoko Nagata, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Y. Kawa, Takashi Irie, Ryoko Kawabata, Ryo Shimizu, Otowa Takahashi, Kimiko Ichihara, Chihiro Motozono, Mako Toyoda, Takamasa Ueno, Yuki Shibatani, Tomoko Nishiuchi, Akatsuki Saito, Keita Matsuno, Kazuo Takayama, Takao Hashiguchi, Shinya Tanaka, Takasuke Fukuhara, Terumasa Ikeda, Kei Sato - Nature Communications 2023 cited by 157

  8. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin Kuramochi, M. Seki, Ryoji Fujiki, Atsushi Kaneda, Tadanaga Shimada, Taka‐aki Nakada, Seiichiro Sakao, Takuji Suzuki, Takamasa Ueno, Akifumi Takaori‐Kondo, Ken J. Ishii, Gideon Schreiber, Hirofumi Sawa, Akatsuki Saito, Takashi Irie, Shinya Tanaka, Keita Matsuno, Takasuke Fukuhara, Terumasa Ikeda, Kei Sato - Cell 2022 cited by 352

  9. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Sadamasu, Kazuhisa Yoshimura, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Jin Kuramochi, Gideon Schreiber, Ken J. Ishii, Takao Hashiguchi, Terumasa Ikeda, Akatsuki Saito, Takasuke Fukuhara, Shinya Tanaka, Keita Matsuno, Kei Sato - Cell 2022 cited by 297

  10. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuki Yamamoto, Tetsuharu Nagamoto, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Takamasa Ueno, Gideon Schreiber, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Hirofumi Sawa, Takashi Irie, Takao Hashiguchi, Kazuo Takayama, Keita Matsuno, Shinya Tanaka, Terumasa Ikeda, Takasuke Fukuhara, Kei Sato - Cell Host & Microbe 2022 cited by 172

  11. Virological characteristics of the SARS-CoV-2 BA.2.86 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jiří Zahradník, Terumasa Ikeda, Kazuo Takayama, Keita Matsuno, Takasuke Fukuhara, Kei Sato - Cell Host & Microbe 2024 cited by 99

  12. Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5

    Authors: , , , , , , , , , , - The Lancet Infectious Diseases 2023 cited by 70

  13. Neutralisation sensitivity of SARS-CoV-2 omicron subvariants to therapeutic monoclonal antibodies

    Authors: , , , , , , - The Lancet Infectious Diseases 2022 cited by 209

  14. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Konstantin M. J. Sparrer, Frank Kirchhoff - Nature Communications 2021 cited by 190

  15. Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hayato Ito, Keita Matsuno, Hirofumi Sawa, Naganori Nao, Shinya Tanaka, Masumi Tsuda, Lei Wang, Yoshikata Oda, Zannatul Ferdous, Kenji Shishido, So Nakagawa, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Kayoko Nagata, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Kazuo Takayama, Rina Hashimoto, Sayaka Deguchi, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Takao Hashiguchi, Tateki Suzuki, Kanako Kimura, Jiei Sasaki, Yukari Nakajima, Hisano Yajima, Takashi Irie, Ryoko Kawabata, Kaori Tabata, Terumasa Ikeda, Hesham Nasser, Ryo Shimizu, MST Monira Begum, Michael Jonathan, Yuka Mugita, Otowa Takahashi, Kimiko Ichihara, Takamasa Ueno, Chihiro Motozono, Mako Toyoda, Akatsuki Saito, Maya Shofa, Yuki Shibatani, Tomoko Nishiuchi, Kei Sato - The Lancet Microbe 2024 cited by 45

  16. SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation Variant

    Authors: , , , , , , , , , - Cell Reports 2020 cited by 439

  17. Reconstitution of prospermatogonial specification in vitro from human induced pluripotent stem cells

    Authors: , , , , , , , , - Nature Communications 2020 cited by 147

  18. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ryoko Kawabata, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Tateki Suzuki, Yukari Nakajima, Zannatul Ferdous, Kenji Shishido, Yuka Mugita, Otowa Takahashi, Kimiko Ichihara, Yu Kaku, Naoko Misawa, Ziyi Guo, Alfredo A. Hinay, Yusuke Kosugi, Shigeru Fujita, Jarel M. Tolentino, Chen Luo, Lin Pan, Mai Suganami, Mika Chiba, Ryo Yoshimura, Kyoko Yasuda, Keiko Iida, Naomi Ohsumi, Adam Strange, Yuki Shibatani, Tomoko Nishiuchi, Shiho Tanaka, Olivia Putri, Gustav Joas, Yoonjin Kim, Daichi Yamasoba, Kazuhisa Yoshimura, Kenji Sadamasu, Mami Nagashima, Hiroyuki Asakura, Isao Yoshida, So Nakagawa, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Kayoko Nagata, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Takamasa Ueno, Chihiro Motozono, Mako Toyoda, Terumasa Ikeda, Akatsuki Saito, Keita Matsuno, Jumpei Ito, Shinya Tanaka, Kei Sato, Takao Hashiguchi, Kazuo Takayama, Takasuke Fukuhara, Kazuo Takayama, Takasuke Fukuhara - Nature Communications 2024 cited by 89

  19. Virological characteristics of the SARS-CoV-2 XEC variant

    Authors: , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2024 cited by 59

  20. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shigeru Fujita, Mai Suganami, Mika Chiba, Ryo Yoshimura, So Nakagawa, Jiaqi Wu, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Kayoko Nagata, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Takao Hashiguchi, Tateki Suzuki, Kanako Kimura, Jiei Sasaki, Yukari Nakajima, Ayaka Sakamoto, Naoko Yasuhara, Takashi Irie, Ryoko Kawabata, Terumasa Ikeda, Hesham Nasser, Ryo Shimizu, Monira Begum, Otowa Takahashi, Kimiko Ichihara, Takamasa Ueno, Chihiro Motozono, Mako Toyoda, Akatsuki Saito, Yuri Tanaka, Erika P. Butlertanaka, Maya Shofa, Kaori Tabata, Isao Yokota, Keita Matsuno, Kazuo Takayama, Shinya Tanaka, Kei Sato, Takasuke Fukuhara - Communications Biology 2023 cited by 64

  21. Virological characterization of the 2022 outbreak‐causing monkeypox virus using human keratinocytes and colon organoids

    Authors: , , , , , , , - Journal of Medical Virology 2023 cited by 41

  22. SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion

    Authors: , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 cited by 175

  23. N4BP1 restricts HIV-1 and its inactivation by MALT1 promotes viral reactivation

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Microbiology 2019 cited by 79

  24. Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes

    Authors: , , , , , , , , , - Circulation 2013 cited by 176